Healthcare Analytics, Population Health Management, Healthcare Big Data

Personalized Medicine

FDA: Real-World Data, Machine Learning Critical for Clinical Trials

January 31, 2019 - Real-world data gathered directly from EHRs and other data sources, paired with advances in machine learning, will be crucial for architecting the next generation of successful clinical trials, says FDA Commissioner Dr. Scott Gottlieb. In a speech to the Bipartisan Policy Center on January 28, Gottlieb stressed the importance of modernizing the clinical trial process to take advantage...


More Articles

NIH Integrates Fitbit Data into “All of Us” Research Program

by Jennifer Bresnick

Participants in the NIH All of Us research program can now volunteer their FitBit data to better inform the national population health research initiative. Digital health technologies, including Internet of Things (IoT) devices such as...

NorthShore to Add Genomic Data to Primary Care for 10K Patients

by Jennifer Bresnick

Illinois-based NorthShore University HealthSystem is partnering with Color to bring genomic data into the decision-making process for primary care. The DNA10K initiative will engage more than 10,000 patients to integrate genomic testing...

23andMe, Lark Health Join Genetics, AI, Diabetes Prevention

by Jennifer Bresnick

Consumer genetic test company 23andMe has announced a partnership with Lark Health, provider of AI-driven health coaching programs, to allow consumers to use genetic test results to inform their approach to wellness. The...

Vanderbilt, GE Healthcare Partner for AI-Driven Immunotherapy

by Jennifer Bresnick

Vanderbilt University Medical Center (VUMC) and GE Healthcare have announced a new partnership aimed at applying artificial intelligence to developing immunotherapy for cancer patients. The five-year collaboration will create predictive...

Effective Precision Medicine Requires Moving Beyond the EHR

by Jennifer Bresnick

Electronic health records are not enough to support truly effective precision medicine at the point of care, said providers participating in a survey from KLAS research, but more targeted health IT tools are producing high rates of...

FDA Clears 23andMe Genetic Test for Medication Metabolism Variants

by Jennifer Bresnick

Consumers will now be able to purchase an over-the-counter test to screen for genetic variants that may influence medication metabolism, the FDA has announced. The direct-to-consumer test from 23andMe is a first for the American market,...

Consumers Curious About AI, Genetic Testing for Precision Medicine

by Jennifer Bresnick

Healthcare consumers are cautious but optimistic that emerging strategies like artificial intelligence and advanced genetic testing can lead to better care for cancer, according to a new survey from McKesson and Ipsos. The poll of more...

Amazon, APIs to Support Cloud Informatics Platform for Life Sciences

by Jennifer Bresnick

Amazon Web Services (AWS), Accenture, and Merck have announced a collaboration to create a cloud-based informatics research platform to support advances in the life sciences. The project will accelerate drug development by improving...

Using Big Data, Machine Learning to Reduce Chronic Disease Spending

by Jessica Kent

Diabetes and heart disease are two of the most costly and prevalent chronic conditions impacting patients in the US, leading the healthcare industry to spend billions every year to treat and manage these disorders. As care delivery...

$21M Grant to “All of Us” Orgs Will Support Precision Medicine Research

by Jessica Kent

The HHS Health Resources and Services Administration (HRSA) has awarded $21 million to 46 community health centers to support their participation in NIH’s All of Us precision medicine research program. The grant will allow community...

How to Bring Precision Medicine into Routine Clinical Care

by Jessica Kent

Precision medicine has taken the healthcare industry by storm in recent years, offering the promise of more individualized treatments, improved patient outcomes, and a deeper understanding of genetic conditions and rare...

NCI Studies Link Dozens of Genetic Variants to Cancer

by Jessica Kent

The discovery of genetic variants that are associated with cancer development could assist providers with identifying high-risk patients and crafting precision medicine therapies for oncology, according to new research funded by the...

Broader Availability of Genetic Testing a Boon for Precision Care

by Jennifer Bresnick

Precision medicine is quickly moving out of the realm of science fiction and into the everyday routines of oncologists, neurologists, and other providers treating patients who may have had little hope just a few short years ago. While the...

Cleveland Clinic Sets Up New Biobank for Clinical, Genomic Research

by Jessica Kent

Cleveland Clinic and Brooks Automation have announced a new biobank facility to enhance research on human tissue samples and improve clinical care for several conditions, including cancer, heart disease, and epilepsy. "This new...

Genomic Medicine Initiatives Aid Undiagnosed Pediatric Patients

by Jessica Kent

Three pediatric medical centers have introduced genomic medicine initiatives aimed at accelerating diagnoses and treatment for children with unexplained illnesses. Nicklaus Children’s Hospital of Miami, in collaboration with Rady...

Intermountain Launches Prospective Precision Medicine Study

by Jennifer Bresnick

Intermountain Healthcare is launching a new precision medicine project that will allow researchers to take a prospective view on the potential of genomic data. The PRECISE study allows for the collection of fresh-frozen tissue and blood...

NIH Concludes In-Depth Genomic Data Analysis of 33 Cancer Types

by Jessica Kent

The National Institutes of Health (NIH) has completed detailed genomic data analysis of the PanCancer Atlas, a data set of molecular and clinical information from over 10,000 tumors that represent 33 types of cancer. “This project...

Henry Ford to Apply Data Analytics to Pancreatic Cancer with $20M Gift

by Jennifer Bresnick

An anonymous $20 million donation to Henry Ford Health System will help the health system leverage big data analytics for the early detection and better treatment of pancreatic cancer. The Henry Ford Pancreatic Cancer Center will focus on...

Healthy Nevada Study Combines Genomics, Population Health

by Jennifer Bresnick

A unique population health study in Nevada is combining genomic information from thousands of citizens with socioeconomic, environmental, and clinical data to develop insights into how lifestyle interacts with genetics. The Healthy Nevada...

X

Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy


no, thanks

Continue to site...